News & Updates

Show Multimedia Only

Exercise training after lung surgery improves quality of life

26 Dec 2021

Postoperative exercise training has the potential to increase the quality of life of patients undergoing lung surgery, according to the results of a systematic review and meta-analysis.

26 Dec 2021

Sintilimab-IBI305-chemo improves PFS in EGFRm non-squamous NSCLC

24 Dec 2021 by

The combination of the anti-PD-1 monoclonal antibody sintilimab with the bevacizumab biosimilar IBI305 and pemetrexed and cisplatin chemotherapy improved progression-free survival (PFS) in patients with EGFR*-mutated (EGFRm) non-squamous non-small-cell lung cancer (NSCLC), according to interim analysis results of the phase III ORIENT-31 trial from China.

24 Dec 2021

BP levels on the rise during the COVID-19 pandemic

22 Dec 2021 by

Among the many damages that COVID-19 pandemic has brought about, researchers found that increase in blood pressure levels (BP) was one of them, at least among US adults — which could have far reaching health consequences in the long term.

22 Dec 2021

Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy

20 Dec 2021 by

Mild-to-moderate COVID-19 during pregnancy does not appear to affect the foetal brain, according to a prospective study presented at RSNA 2021.

20 Dec 2021

Extracorporeal CO2 removal safe, effective for acute exacerbation of COPD

20 Dec 2021 by

Extracorporeal CO2 removal (ECCO2R) devices significantly improve pH and carbon dioxide arterial pressure (PaCO2) in patients with acute exacerbation of chronic obstructive pulmonary disease (ae-COPD) who had previously failed noninvasive ventilation (NIV), according to a recent study.

20 Dec 2021

Physical frailty prognostic of disability, mortality in COPD

19 Dec 2021

Chronic obstructive pulmonary disease (COPD) patients frequently develop physical frailty, which provides prognostic information, a study has found.

19 Dec 2021

Pfizer's COVID-19 antiviral pills yield EPIC results for hospitalization, deaths

19 Dec 2021 by

A new oral COVID-19 antiviral therapy comprising nirmatrelvir and ritonavir substantially slashes the risk of hospitalization or death compared with placebo in nonhospitalized adults with COVID-19 who are at high risk of developing severe illness, according to final analysis of the EPIC-HR* study.

19 Dec 2021

Early-life exposures to smoking, infection, abuse up risk of COPD in adulthood

19 Dec 2021

Childhood respiratory disease, maltreatment, maternal smoking, and low birth weight are all associated with an increased risk of chronic obstructive pulmonary disease (COPD) in adulthood, a study has found.

19 Dec 2021

Former smokers with COVID-19 face higher risk of death

17 Dec 2021

In a cohort of veterans with COVID-19, former smokers are at higher risk of 30-day mortality compared with current smokers and nonsmokers, as reported in a study.

17 Dec 2021

No benefit from adding interferon beta-1a to remdesivir in COVID-19

16 Dec 2021 by

Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.

16 Dec 2021

News & Updates

Showing Respirology articles

Showing

Specialty:

Exercise training after lung surgery improves quality of life

Sintilimab-IBI305-chemo improves PFS in EGFRm non-squamous NSCLC

BP levels on the rise during the COVID-19 pandemic

Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy

Extracorporeal CO2 removal safe, effective for acute exacerbation of COPD

Physical frailty prognostic of disability, mortality in COPD

Pfizer's COVID-19 antiviral pills yield EPIC results for hospitalization, deaths

Early-life exposures to smoking, infection, abuse up risk of COPD in adulthood

Former smokers with COVID-19 face higher risk of death

No benefit from adding interferon beta-1a to remdesivir in COVID-19